Sort
89,613 grants matching “depression”
Efficacy of intravenous sub-dissociative ketamine versus intravenous morphine in children with acute pain.
$3,238,659Daniel Sing-Kwong Tsze · Columbia University Health Sciences · U01 · FY2025 · HD
The Center for Enhancing Treatment and Utilization for Depression and Emergent Suicidality (ETUDES) in Pediatric Primary Care
$3,237,322David A. Brent · University Of Pittsburgh At Pittsburgh · P50 · FY2024 · MH
The Center for Accelerating Practices to End Suicide through Technology Translation (CAPES)
$3,236,806Edwin D Boudreaux · Univ Of Massachusetts Med Sch Worcester · P50 · FY2024 · MH
IGF::OT::IGF Double-Blind, Placebo-Controlled, Proof-of-Concept (POC) Trial of LY
$3,236,602X X · Massachusetts General Hospital · N02 · FY2013 · DA
The Center for Enhancing Treatment and Utilization for Depression and Emergent Suicidality (ETUDES) in Pediatric Primary Care
$3,233,681David A. Brent · University Of Pittsburgh At Pittsburgh · P50 · FY2025 · MH
fMRI Studies of Pediatric Mood and Anxiety Disorders
$3,233,142Daniel Pine · National Institute Of Mental Health · ZIA · FY2023 · MH
Conte Center: Understanding Latent Cause Inference in Health and Illness
$3,225,980Yael Niv · Princeton University · P50 · FY2024 · MH
Novel Treatment Targets For Affective Disorders Through Cross-Species Investigation of Approach/Avoidance Decision Making
$3,225,604Diego A. Pizzagalli · Mclean Hospital · P50 · FY2020 · MH
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
$3,225,056Richard M Weinshilboum · Mayo Clinic Rochester · U19 · FY2011 · GM
Displacement-guided focused ultrasound for pain modulation.
$3,220,027Elisa E Konofagou · Columbia University Health Sciences · R18 · FY2025 · EB
Alzheimer's Disease Research Center
$3,214,632Thomas M Wisniewski · New York University School Of Medicine · P30 · FY2022 · AG
Mechanisms Of Synaptic Plasticity In The Adult And Developing Nervous System
$3,213,326Serena M Dudek · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES
Suicide Care Research Center
$3,212,280Katherine Anne Comtois · University Of Washington · P50 · FY2024 · MH
Conte Center: Understanding Latent Cause Inference in Health and Illness
$3,210,120Yael Niv · Princeton University · P50 · FY2025 · MH
Selective Control of Synaptically-Connected Circuit Elements by Interluminescence
$3,208,469Ute H Hochgeschwender · Central Michigan University · R01 · FY2021 · NS
The Center for Accelerating Practices to End Suicide through Technology Translation (CAPES)
$3,202,112Edwin D Boudreaux · Univ Of Massachusetts Med Sch Worcester · P50 · FY2025 · MH
Sleep and Neurodevelopment Service
$3,192,672Ashura Buckley · National Institute Of Mental Health · ZIA · FY2025 · MH
Mapping amyloid, tau, and neurodegeneration markers with neuropsychiatric phenotypes and genotypes in Alzheimer's disease continuum using machine learning
$3,188,901Ganesh Chand · Washington University · RF1 · FY2025 · AG
Role of PS1 in neurodegeneration
$3,188,744Oksana Berezovska · Massachusetts General Hospital · RF1 · FY2019 · AG
Fatty Acid Amide Hydrolase (FAAH) Inhibitor Treatment of Cannabis Use Disorder (CUD)
$3,184,864Deepak Cyril D'souza · Yale University · U01 · FY2017 · DA
Integrative genetics of behavior with high throughput technologies
$3,183,826David Goldman · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2015 · AA
Arylepoxamides: A new class of potent, safer analgesics
$3,182,170Ying-Xian Pan · Sloan-Kettering Inst Can Research · UG3 · FY2020 · DA
NIMH Space Activation, Maintenance, and Improvement
$3,181,406Susan Amara · National Institute Of Mental Health · ZII · FY2020 · MH
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)
$3,180,681Kimford J Meador · Stanford University · U01 · FY2020 · NS
Family Study of Affective and Anxiety Spectrum Disorders
$3,176,791Kathleen R Merikangas · National Institute Of Mental Health · ZIA · FY2025 · MH